另一个十年的抗疟疾药物发现:新的标,工具和分子
John G Woodland1, André Horatscheck2, Candice Soares de Melo2
1Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, South Africa; South African Medical Research Council Drug Discovery and Development Research Unit, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Progress in medicinal chemistry
|October 6, 2024
概括
由于耐药性,发现新的抗疟疾药物至关重要. 全球努力集中在新的目标上,如Plasmodium falciparum ATPase4 (ATP4) 和新的药物类别,以有效打击疟疾.
科学领域:
- 药物的发现和开发.
- 传染病研究传染病研究.
- 药品化学 药品化学 是一个
背景情况:
- 疟疾是全球主要的健康挑战,特别是在非洲,对现有治疗方法的耐药性日益增加.
- 迫切需要新的抗疟疾标和疗法,以克服交叉耐药性并提高治疗疗效.
- 在过去的十年中,药物发现方面取得了重大进展.
研究的目的:
- 审查当前的全球抗疟疾药物发现和开发计划.
- 突出发现新的抗疟疾标和开发新型药物类别的进展.
- 讨论针对特定的Plasmodium falciparum蛋白质和激酶的好处和挑战.
主要方法:
- 审查正在进行的全球抗疟疾药物发现计划.
- 识别新型药物标,包括Plasmodium falciparum ATPase4 (ATP4),乙-CoA合成酶 (AcAS) 和蛋白质翻译机制.
- 检查Plasmodium激酶,如循环GMP依赖蛋白激酶 (PKG),循环素依赖类似蛋白激酶3 (CLK3) 和酸丁醇4-激酶 (PI4K).
- 使用诸如NOD scid gamma (NSG) 这样的工具,为目标验证提供了人性化的小鼠模型.
- 在药物发现中利用预测建模和开源软件.
主要成果:
- 在识别和验证新的抗疟疾药物标的进展.
- 开发新的药物类别,针对重要寄生虫蛋白和酶.
- 在加速目标验证和药物开发的工具方面取得了进展.
- 探索向Plasmodium falciparum ATPase4 (ATP4),乙-CoA合成酶 (AcAS),氨基酸-tRNA合成酶 (aaRSs) 和真核生物延长因子2 (eEF2) 的研究.
- 对向Plasmodium激酶 (PKG,CLK3,PI4K) 的潜力的分析.
结论:
- 全球社区在发现抗疟疾药物方面取得了重大进展.
- 新的目标和药物类别正在出现,以对抗抗性疟疾菌株.
- 开发先进的工具和协作努力,包括非洲的中心,对于未来的成功至关重要.
- 持续的国际合作对于团结抗疟疾药物发现社区至关重要.
相关概念视频
01:26Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
01:28Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
01:24Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K